You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 91 No. 6, JUNE 1953 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

VITAMIN E AND CLIMACTERIC SYNDROME

Failure of Effective Control as Measured by Menopausal Index

MEYER H. G. BLATT, M.D.; HANS WIESBADER, M.D.; HERBERT S. KUPPERMAN, M.D., Ph.D.

AMA Arch Intern Med. 1953;91(6):792-799.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WHILE the value of estrogens in the menopause cannot be denied, there are some clinicians who condemn their use for the climacteric patient. The condemnation is based upon three primary concepts: One is that the entire climacteric syndrome has been designated as one of psychodynamic alterations and can, therefore, be controlled very adequately by psychotherapy or barbiturate sedation.1 Secondly, evidence of the carcinogenic propensity of estrogens in mice2 and occasionally in rats has led to the feeling that similar results could be anticipated clinically.3 The third objection to the use of estrogens in the female climacteric is that in the past a tendency towards uterine bleeding has been noted in patients maintained on estrogen therapy. However, recent moderation of the original recommended doses has diminished the incidence of bleeding noted after such hormone medication.4 In an attempt to appease those who feel nihilistic toward estrogen therapy, an intensive search has . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the Departments of Obstetrics and Gynecology and Therapeutics, New York University College of Medicine and the Obstetrical and Gynecological Service of the Third (New York University) Surgical Division, Bellevue Hospital.


Footnotes

This study was supported by a Grant-in-Aid from the Committee for the Promotion of Medical Research, Incorporated.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1953 American Medical Association. All Rights Reserved.